Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bridgewest Group
San Diego, California, United Statesbridgewestgroup.com ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
Bridgewest Group itself does not have clinical results, but its portfolio companies (e.g., BioAtla, NovaCina, BioOra, BioDuro-Sundia) operate across preclinical to commercial stages and have established technologies in clinical and commercial biomanufacturing, antibody and protein therapeutics, and cell therapies.[1][2][5]
- Modalities
- Small moleculeLarge moleculeCell therapyMonoclonal antibodyProteinCAR-T cell therapy
- Industry
- Investors
02
Partnerships
Malaghan Institute of Medical Research (via BioOra partnership)New Zealand Government (via BVNZ deep tech incubator partnership)
Beyond the preview
Go deeper on Bridgewest Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bridgewest Group.